JOHNSON & JOHNSON Operating Cash Flow 2007-2025 | JNJ
Beta
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is JOHNSON & JOHNSON's current operating cash flow?
JOHNSON & JOHNSON (JNJ) annual operating cash flow for 2025 was $24.53B, a 1.09% increase from 2024. JOHNSON & JOHNSON operating cash flow for the quarter ending December 28, 2025 was $7.31B.
What was JOHNSON & JOHNSON's operating cash flow in 2024?
JOHNSON & JOHNSON annual operating cash flow for 2024 was $24.27B, a 6.47% increase from 2023.
What was JOHNSON & JOHNSON's operating cash flow in 2023?
JOHNSON & JOHNSON annual operating cash flow for 2023 was $22.79B, a 2.64% decline from 2022.
What is JOHNSON & JOHNSON's 4-year operating cash flow CAGR?
JOHNSON & JOHNSON operating cash flow grew at a compound annual growth rate (CAGR) of 1.04% from FY2021 to FY2025, going from $23.54B to $24.53B over 4 years.
Operating Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+0.9%
FY2019
$23.42B
→
FY2025
$24.53B
07081011121314161718192122232425
5 years selected
Operating Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $24.53B | +1.1% | 10-K |
| FY2024 | $24.27B | +6.5% | 10-K |
| FY2023 | $22.79B | -2.6% | 10-K |
| FY2022 | $23.41B | -0.5% | 10-K |
| FY2021 | $23.54B | +0.5% | 10-K |
| FY2019 | $23.42B | +5.5% | 10-K |
| FY2018 | $22.20B | +5.4% | 10-K |
| FY2017 | $21.06B | +7.6% | 10-K |
| FY2016 | $19.57B | +4.6% | 10-K |
| FY2014 | $18.71B | +7.4% | 10-K |
| FY2013 | $17.41B | +13.1% | 10-K |
| FY2012 | $15.40B | -6.0% | 10-K |
| FY2011 | $16.39B | -1.1% | 10-K |
| FY2010 | $16.57B | +10.7% | 10-K |
| FY2008 | $14.97B | -0.3% | 10-K |
| FY2007 | $15.02B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →